IRIS
MARTORANA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.355
AS - Asia 4.288
EU - Europa 3.420
SA - Sud America 547
AF - Africa 73
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 38.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.232
SG - Singapore 2.209
IT - Italia 822
CN - Cina 685
DE - Germania 455
BR - Brasile 454
RU - Federazione Russa 434
UA - Ucraina 394
HK - Hong Kong 363
VN - Vietnam 316
IE - Irlanda 299
FR - Francia 238
GB - Regno Unito 196
BD - Bangladesh 188
KR - Corea 133
FI - Finlandia 128
JP - Giappone 115
NL - Olanda 114
SE - Svezia 104
PL - Polonia 94
CA - Canada 71
IN - India 67
AR - Argentina 40
AT - Austria 31
TR - Turchia 28
ID - Indonesia 27
MX - Messico 26
ES - Italia 23
ZA - Sudafrica 23
UZ - Uzbekistan 20
CZ - Repubblica Ceca 19
BE - Belgio 18
IQ - Iraq 17
EC - Ecuador 16
KG - Kirghizistan 14
PH - Filippine 14
SA - Arabia Saudita 14
CL - Cile 13
AU - Australia 12
EU - Europa 12
PK - Pakistan 12
KE - Kenya 11
MY - Malesia 10
MA - Marocco 9
PY - Paraguay 9
JO - Giordania 8
TN - Tunisia 8
CR - Costa Rica 7
DK - Danimarca 6
VE - Venezuela 6
BG - Bulgaria 5
CH - Svizzera 5
IL - Israele 5
LT - Lituania 5
NP - Nepal 5
AZ - Azerbaigian 4
CO - Colombia 4
EG - Egitto 4
ET - Etiopia 4
GR - Grecia 4
OM - Oman 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CG - Congo 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
MD - Moldavia 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DM - Dominica 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
ZM - Zambia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BM - Bermuda 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
KH - Cambogia 1
Totale 38.692
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.025
Wilmington 7.325
Houston 7.090
Fairfield 1.069
Singapore 996
Ann Arbor 667
Ashburn 656
San Jose 541
Chandler 466
Seattle 431
Hong Kong 357
Cambridge 342
Jacksonville 330
Beijing 280
Dublin 279
Rome 243
Medford 218
Dearborn 211
New York 192
Santa Clara 150
Council Bluffs 134
Los Angeles 118
The Dalles 110
Ho Chi Minh City 103
Lawrence 102
Tokyo 101
Moscow 80
Lauterbourg 73
Hanoi 72
Munich 72
Buffalo 66
Kraków 62
San Diego 60
Milan 57
Mülheim 51
São Paulo 46
Helsinki 44
Menlo Park 43
Zhengzhou 42
Chicago 36
Dallas 36
Manchester 35
London 31
Norwalk 29
Palo Alto 28
Warsaw 28
Redondo Beach 24
Atlanta 23
Maastricht 23
Naples 23
Nuremberg 23
Orem 23
Rio de Janeiro 21
Toronto 21
Brooklyn 20
Redwood City 20
Chennai 19
Johannesburg 19
Monte Vista 19
Montreal 19
Brussels 18
Hangzhou 18
Vienna 18
Amsterdam 17
Da Nang 17
North Bergen 17
San Francisco 17
Verona 17
Düsseldorf 16
Frankfurt am Main 16
Phoenix 16
Boardman 15
Brno 15
Tashkent 15
Columbus 14
Stockholm 14
Poplar 13
Seoul 13
Shanghai 13
Dhaka 12
Falls Church 12
Hefei 12
Jakarta 12
University Park 12
Belo Horizonte 11
Denver 11
Guangzhou 11
Pieve a Nievole 11
Saint Petersburg 11
Turku 11
Biên Hòa 10
Brasília 10
Del Norte 10
Ferrara 10
Mexico City 10
Miami 10
Palermo 10
Boston 9
Haiphong 9
Madrid 9
Totale 32.346
Salva come PNG Salva come JPEG
Nome #
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 596
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 521
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 518
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 506
Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry 498
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 494
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 491
Transient global amnesia: linked to a systemic disorder of amino acid catabolism? 488
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients 481
Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease 479
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. 478
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? 475
"Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" 470
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 469
Impaired LTP- but not LTD-Like Cortical Plasticity in Alzheimer's Disease Patients 468
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 463
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 462
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 462
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 462
Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene 460
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 459
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 457
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease 456
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 455
Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients 455
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain 453
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 450
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? 447
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients 447
Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients 445
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 443
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 440
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 439
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 438
Immunolocalization of CB1 receptor in rat striatal neurons: a confocal microscopy study 436
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 436
Huntingtin distribution among striatal output neurons of normal rat brain 434
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 434
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex 434
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 432
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins 431
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain. 431
Reversal of LTP-Like cortical plasticity in Alzheimer's disease patients with tau-related faster clinical progression 425
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 422
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 422
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 419
Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? 417
Tissue plasminogen activator is required for corticostriatal long-term potentiation 415
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease. 414
Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease. 414
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 413
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? 413
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra 412
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 411
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes. 411
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities 408
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 406
Plasmin system of Alzheimer's disease patients: CSF analysis 406
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 404
L-dopa modulates motor cortex excitability in Alzheimer's disease patients 401
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 394
Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms 389
Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle 388
Frailty among Alzheimer's disease patients 386
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension 377
Is dopamine involved in Alzheimer's disease? 376
Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients 370
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study. 367
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 365
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients. 360
The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients 355
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity 355
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 353
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 318
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 314
Assessment of serum uric acid as risk factor for tauopathies 305
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 304
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 257
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 246
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 229
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 222
Alzheimer’s disease and the routine clinical use of CSF biomarkers 202
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 198
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 192
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 184
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 175
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 172
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 171
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 157
Insulin and the future treatment of Alzheimer’s disease 156
Ageing as a Trait de Union between diabetes and dementia for frailty 150
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 146
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State 143
Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease 133
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 122
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 121
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 112
Breakdown of TMS evoked EEG signal propagation within the default mode network in Alzheimer’s disease 110
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 108
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 106
Totale 36.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/20221.167 55 158 86 37 32 114 55 88 71 80 73 318
2022/20231.285 144 111 45 131 100 297 109 58 114 16 109 51
2023/2024498 58 16 31 25 42 148 20 44 10 10 6 88
2024/20253.079 84 631 289 162 77 222 132 117 305 259 405 396
2025/20265.638 394 230 523 439 480 180 745 662 681 525 470 309
Totale 39.172